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a b s t r a c t
Avian inﬂuenza virus H5N1 has caused extensive damage worldwide among poultry and humans. Effec-
tive expression systems are needed for the production of viral proteins required for monitoring this
devastating disease. The present study deals with the establishment of a stable expression system for the
hemagglutinin H5 (HAH5) of avian inﬂuenza virus using CHO cells in suspension culture transduced with
a recombinant lentiviral vector. The synthetic gene coding the HAH5 protein was inserted in a lentiviral
vector with the aim of performing a stable transduction of CHO cells. After the selection of recombinant
clones, the onewith the highest expression levelwas adapted to suspension culture and theHAH5 protein
was puriﬁed by immunoafﬁnity chromatography from the culture supernatant. Therewere no signiﬁcant
differences when this protein, puriﬁed or direct from the culture supernatant of CHO or SiHa cells, was
utilized in an immunologic assay using positive and negative sera as reference. It was also demonstrated
that the HAH5 protein in its puriﬁed form is able to bind anti-HAH5 antibodies generated with proper
and non-proper folded proteins. The results demonstrate that the CHO cell line stably transduced with
a lentiviral vector coding the sequence of the HAH5 protein and cultured in suspension can be a suitable
expression system to obtain this protein for diagnostic purpose in a consistent and reliable manner.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND. Introduction
Since 2003, several outbreaks of the highly pathogenic avian
nﬂuenza virus (HPAIV) H5N1 have occurred in Southeast Asia.
his virus spread across Africa and Europe causing the loss of
illions of birds and the death of more than 380 humans until
ow (http://www.who.int/inﬂuenza/human animal interface/). As
5N1 virus obviously represents a threat all over the world, sev-
ral attempts have been made to produce better new generation
accines and diagnostic systems for counteracting the dissemi-
ation of this virus and reinforcing the surveillance [1–4]. The
rotein hemagglutinin (HA) of inﬂuenza viruses has been consid-
red the main antigen during the host immune response against
he infection. There are 17 subtypes of avian inﬂuenza virus based
∗ Corresponding author. Tel.: +53 7 250 4412; fax: +53 7 271 4764.
E-mail address: alain.pose@cigb.edu.cu (A.G. Pose).
ttp://dx.doi.org/10.1016/j.btre.2014.05.001
215-017X/© 2014 The Authors. Published by Elsevier B.V. This is an open access article unlicense (http://creativecommons.org/licenses/by-nc-nd/3.0/).
on the antigenic drift of the HA protein [5]. Thus, the HA protein
could be crucial for the detection of these viruses. Because the sub-
type H5 is one of the avian inﬂuenza subtypes that can turn into
highly pathogenic viruses, surveillance programs should include
diagnostic techniques able to detect this avian inﬂuenza subtype.
Hence, the HAH5 protein could be useful for this purpose. The HA
protein has been obtained employing several expression systems,
such as bacteria [6], yeasts [7], insect cells using baculovirus vec-
tors [1] and mammalian cells transduced with adenoviral vectors
[8]. Moreover, plenty of studies have demonstrated the efﬁcacy of
mammalian cells in the expression of heterologous proteins [9].
Among them, Chinese hamster ovary (CHO) is a very well charac-
terized mammalian cell line and is one of the most used expression
system for the production of recombinant proteins applied to
humans [10]. Therefore, regulatory issues are easier to overcome
using this cell line.On theotherhand, lentiviral vectorshave risenas
a promising tool for the stable transformation of mammalian cells.
They have several advantages compared to other methodologies
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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tilized for this purpose, such as the stable transformationwith cal-
iumphosphate or theuseof polycations. Someof these advantages
re: (i) the integration in active sites of chromatin, (ii) the transduc-
ion of dividing and quiescent cells, (iii) the integration of longer
NA fragments and (iv) the long term expression of the transgene
11]. Therefore, the objective of this study was to generate a stable
ransformed CHO cell line in suspension culture able to produce
he HA protein from the highly pathogenic inﬂuenza virus H5N1
A/Viet-Nam/1203/2004) for diagnostic purpose by transduction
ith a recombinant lentiviral vector.
. Materials and methods
.1. The hemagglutinin gene
The nucleotide sequence of theHAH5 proteinwas obtained from
heNational Center for Biotechnology Information (NCBI) using the
ccession number AY818135. The hah5 gene was synthesized by
eneArt company (Germany) and encodes amino acids from 1 to
37, which include the native secretion signal of the HAH5 protein.
t lacks transmembrane region and cytoplasmic tail [2].
.2. Insertion of the ha gene into the plasmids pAEC-Spt and pLW
The hah5 gene was extracted from the vector supplied by
eneArt company with the enzymes Kpn I/EcoR V and inserted
n the mammalian expression plasmid pAEC-Spt [12] previously
igested with the same enzymes. The recombinant plasmid was
amed pAEC-hah5. For the cloning of the ha gene into the plas-
id pLW [35], it was ampliﬁed from the plasmid pAEC-hah5 (10ng
f template) by PCR using an automatic Mastercycler (Eppendorf,
SA), the Pfu DNA polymerase (Promega, USA) and the primers:
forward) 5′-ACTAGTTATTAATAGTAATCAATTACG-3′ and (reverse)
′-CCAATTATGTCACACCACAG-3′. Three minutes at 93 ◦C were pro-
rammed as the initial step, followed by 35 cycles of 1min at 93 ◦C,
min at 52 ◦C and 5min at 74 ◦C. A ﬁnal polymerization step of
min at 74 ◦C was added. The ampliﬁed gene was inserted in the
lasmid pLW previously digested with the enzyme EcoR V. The
ecombinant plasmid was named pLW-hah5.
.3. Transfection of the cell line HEK-293 with the plasmid
AEC-hah5
In vitro culture of HEK-293 cell line (ATCC CRL-1573) was car-
ied out in ﬂasks of 25 cm2 (Greiner Bio-One, Germany) using
he culture medium Dulbecco’s modiﬁed Eagle’s medium (DMEM)
Sigma, USA) supplementedwith 10% of fetal calf serum (FCS) (PAA,
anada), 0,3mg/mL of l-glutamine (Sigma, USA), 1mM of sodium
yruvate (Sigma,USA)andanantibiotic–antimycotic solution100×
GibcoBRL, USA) at a ﬁnal concentration of 1×. Cellswere incubated
t 37 ◦C, 5% of CO2 and 95% of relative humidity. One hour before
he transfection, themediumof the cell culture at 80%of conﬂuence
as changed for fresh medium without FCS. Transfection was per-
ormed using the polycation polyethylenimine 25000 (PEI) (Sigma,
SA) at 0,81mg/mL, pH 7 and the plasmids pAEC-hah5 and pEGFP.
he last plasmid was generated by including a transcription unit
ith the enhanced greenﬂuorescent protein (EGFP) gene under the
ontrol of the CMV enhanced promoter into the pMOS-Blue back-
one. DNA was used at 0,72g/cm2. The ratio pAEC-hah5/pEGFP
as 36:1 and the ratio PEI/DNA was 1L/1g. DNA and PEI were
iluted in separate tubes using 5% of glucose until reaching 50L
ach. After sampleswere vigorouslymixed during 10 s and allowed
o stand for 5min, PEI was added to DNA, which were vigorously
ixed during 1min and allowed to stand for 20min. Subsequently,
00L of fresh DMEM was added to the PEI/DNA complex and
he mixture of 1mL was carefully added to the cell culture. Sixeports 3 (2014) 108–116 109
hours later, FCS was added at a ﬁnal concentration of 10%. Negative
control was performed as above but with the plasmid pAEC-Spt.
Transfection was veriﬁed after 72h by observing the production of
the EGFPprotein in transfected cells at theﬂuorescencemicroscope
using a magniﬁcation of 400×.
2.4. Assembly of the recombinant lentiviral vector
Transfection of the HEK-293FT cell line (Invitrogen, USA) with
the plasmids pLP1, pLP2, pLP/VSVG (Invitrogen, USA), pEGFP and
pLW-hah5 was carried out in 6 ﬂasks of 175 cm2 (Greiner Bio-One,
Germany) using PEI as explained above. In each ﬂask, DNA was
used at 0,411g/cm2. The ratio DNA/pEGFP was 36:1 and the ratio
pLW-hah5/each helping plasmid (pLP1, pLP2 and pLP/VSVG) was
2:1. Negative control was performed in the same way but with the
plasmid pLW. Six hours after adding the mixture of PEI/DNA to
the cell culture, FCS was added until reaching 10%. After 48h, the
supernatant was centrifuged at 1000× g, ﬁltered using a pore size
of 0,45m and ultracentrifuged at 25000× g for 1:30h. The super-
natant was removed and lentiviral particles were resuspended in
fresh DMEM. Storage was performed in aliquots of 10L at −70 ◦C
until use. The recombinant lentiviral vector was named Lv-hah5.
2.5. Transduction of the CHO cell line with the lentiviral vector
Lv-hah5 and clones isolation
After 24h of seeding 2×103 cells/well of CHO-K1 cells (ATCC
CCL-61) in a 96 wells plate (Greiner Bio-One, Germany) with
DMEM and 10% of FCS, cells were transduced with 10L of the
Lv-hah5 preparation. Twenty-four hours later, culture medium was
replaced by fresh medium. Culture medium was replaced every
24h until cell recovery. The transduction was repeated 3 times.
After transductions, cells were dispersed in plates of 145mm
(Greiner Bio-One, Germany) and cultured until clone expansion
in DMEM with 10% of FCS. Clones were named CHO-HAH5. Once
they were macroscopically visible, a cellular amplifying process
was carried out with the clones of CHO-HAH5 randomly selected,
until reaching conﬂuent monolayers in 6 well plates (Greiner
Bio-One, Germany). Positive clones were selected by taking into
account their ability to produce the HAH5 protein detected in
an ELISA assay described below and by monitoring the inser-
tion of the foreign DNA into the cell genome by PCR. The last
procedure was accomplished using an automatic Mastercycler
(Eppendorf, USA) and the GoTaq® Green Master Mix (Promega,
USA). To amplify a segment of the synthetic hah5 gene, the
primers: (forward) 5′-ATACCATGGGACTGTGTGACCTGGACGGCG-
3′ and (reverse) 5′-GATCTCGAGACACTTGGTGTTACAGTTGCC-3′
were synthesized. Two minutes at 95 ◦C were programmed
as the initial step, followed by 35 cycles of 30 s at 95 ◦C,
30 s at 66 ◦C and 1min at 72 ◦C. A ﬁnal polymerization step
of 5min at 72 ◦C was added. To amplify a segment of the
gene corresponding to the cPPT of the lentiviral backbone
the primers: (forward) 5′-TGGCTGTGGAA AGATACCTAAAGG-3′
and (reverse) 5′-TCGAATGGATCTGTCTCTGTCTCTC-3′ were synthe-
sized. Two minutes at 95 ◦C were programmed as the initial step,
followed by 35 cycles of 30 s at 95 ◦C, 30 s at 56 ◦C and 45 s at 72 ◦C.
A ﬁnal polymerization step of 5min at 72 ◦C was also added. Clones
of CHO-HAH5 were frozen in liquid nitrogen until use.
2.6. Adapting adherent CHO-HAH5 cells to suspension culture
After the CHO-HAH5 cells reached 90% of conﬂuence in DMEM
and 10% of FCS, a medium change was made. DMEM was gradu-
ally substituted by SFM4CHO varying the ratio SFM4CHO/DMEM
as follow: 25/75, 50/50, 75/25 and 100/0 every 72h. Detached
cells were recovered by centrifugation at 400× g for 5min in each
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edium change. Suspension cultures were scaled up to spinners of
l.
.7. Puriﬁcation of the HAH5 protein
The immunoafﬁnity chromatography (IC)puriﬁcationprocessof
he HAH5 protein was the same described by [8] for the HACD pro-
ein. Brieﬂy, a Sepharose 4Bmatrix (Pharmacia, USA) activatedwith
yanogen bromide and coupled to an anti-HA4 monoclonal anti-
ody (Sancti-Spíritus, Cuba) was used to purify the HAH5 protein.
olumnwas equilibratedwith EB buffer (1MNaCl, 20mMTris–HCl
pH 7,4) and 3mMEDTA) at a ﬂow rate of 0,4mL/min. Solution con-
aining the HAH5 protein was concentrated in a 10kDa Sartocon
licemembrane (Sartorius,Germany), supplementedwithTris–HCl
pH 7,4) and NaCl until ﬁnal concentrations of 10mM and 150mM,
espectively andpassed through the column. Afterwashingwith EB
uffer, elutionwas carried outwith 0,1Mof citric acid pH 3. Elution
rops containing the HAH5 protein were immediately collected in
0mM Tris–HCl pH 8. Purity was estimated by densitometric anal-
sis of SDS-PAGE gels stainedwith a Coomassie blue R-250 solution
t 0,05% using the software TDI’s 1D Manager, version 2.0.
.8. Immunologic assays
.8.1. ELISA for the detection and quantiﬁcation of the HAH5
rotein
The detection and quantiﬁcation of the HAH5 protein was
ccomplished as described by [8]. Brieﬂy, polystyrene high binding
icrotiter plates (Costar, USA) were coated with 2,5g/mL of the
onoclonal antibody anti-HA2 (Sancti-Spíritus, Cuba) overnight at
◦C. Plates were washed with PBS plus 0,05% Tween 20 (PBST) and
locked with 1% of bovine serum albumin (BSA) (Sigma, USA) in
MEM medium for 2h at 37 ◦C. After washing with PBST, stan-
ard curve (for quantiﬁcation) and culture samples were added
or 2h at 37 ◦C. Standard curve was performed using values from
00 to 1,56ng/mL of the HAH5 protein puriﬁed by IC and culture
amples were diluted 1:64 in DMEM plus 0,5% BSA. Plates were
ashed with PBST and the monoclonal antibody anti-HA3 con-
ugated to horseradish peroxidase (Sancti-Spíritus, Cuba) diluted
: 20000 was added. After 1h at 37 ◦C, plates were washed with
BST and visualized with 0,04M of 3,3′,5,5′-tetramethylbenzidine
Sigma, USA) in dimethyl sulphoxide using hydrogen peroxide as
ubstrate. Reaction was stopped with 3,5% of sulfuric acid and
bsorbance was measured in a microplate reader model SUNRISE-
ASIC TECAN (Austria) at 450nm. The concentration of the HAH5
rotein in the supernatant was calculated by extrapolating the
ptical density (OD) values of samples into the standard curve
D.
.8.2. ELISA for the detection of anti-HAH5 antibodies
Polystyrene high binding microtiter plates (Costar, USA) were
oated overnight at 4 ◦C with 2,5g/mL of the HAH5 protein
btained from SiHa or CHO cells. The HAH5 protein was used in
pure state or directly from the culture supernatant of both cell
ines. Blocking and wash were performed as above. Serum samples
ere diluted from 1/500 to 1/32000 in DMEM plus 0,5% BSA and
dded to coated plates for 2h at 37 ◦C. The antibody detection in
era of chicken immunized with the HACD protein was performed
t a dilution of 1/1000. After washing with PBST, the monoclonal
ntibody anti-IgG (Y) of chicken conjugated to horseradish perox-
dase (Sigma, USA) diluted 1/30000 in DMEM plus 0,5% BSA was
dded.After 1hat37 ◦C, plateswerewashedwithPBST.Absorbance
easurement was performed as above.eports 3 (2014) 108–116
2.9. Statistical analysis
The statistical procedurewas done using the statistical software
GraphPad Prism v.4.02 (GraphPad, USA). A Kruskal–Wallis test and
a Dunn post-test were performed to compare the OD values of the
HAH5 protein indifferent clonesofCHO-HAH5. TheHAH5 production
by different batches of the clone CHO-HAH5 78 was compared by
the ANOVA test and the Tukey post-test. The OD values obtained in
the ELISA using positive and negative sera with the HAH5 protein
puriﬁed or in the culture supernatant from different expression
systems were compared each time point by the unpaired t-test.
3. Results
3.1. Expression of the synthetic gene coding the HAH5 protein and
the obtaining of stable clones from CHO cells producing this
protein
The cell lineHEK-293was transformed by transient transfection
with the plasmid pAEC-hah5 containing the synthetic gene coding
the HAH5 protein in order to demonstrate its expression (Fig. 1).
As the plasmid pAEC-hah5 (Fig. 1A) was co-transfected with a plas-
mid carrying a transcriptional unit expressing the gene coding the
EGFP protein, transfected cells turned ﬂuorescent after the stim-
ulation with ultraviolet light. The ﬂuorescence was homogeneous
and intense, indicating a high level of transfected cells (Fig. 1B and
C). The production of the HAH5 protein in the transfected cells was
assessed by SDS-PAGE and western blot using a polyclonal serum
(Fig. 1D and E). Several immunoreactive bands were observed in
the sample corresponding to the HAH5 protein under reducing and
non-reducing conditions. The precursor protein HA0 from HPAIV
undergoes a proteolytic processing by endogenous proteases gen-
erating the subunits HA1 andHA2. Thus, under reducing conditions
a partial proteolytic processing corresponding at about 50% of total
protein was observed. Three bands were observed in the western
blot corresponding to the uncleaved precursor protein HAH50 and
the subunits HAH51 and HAH52 with molecular masses of about
75–78kDa, 55kDa and 25kDa, respectively. Under non-reducing
conditions, most of the protein was identiﬁed as the precursor pro-
tein HAH50 and a smear was observed above 200kDa, which could
correspond to multimeric conformations of the HAH5 protein. In
this assay, the functionality of the genetic construction pAEC-hah5
was demonstrated. Also, the results showed that the HAH5 protein
is susceptible to proteolytic cleavage by intracellular proteases.
After verifying the correct expression of the synthetic gene cod-
ing the HAH5 protein, a lentiviral vector was constructed in order
to transduce and stably transform the CHO cell line (Fig. 2A). After
transduction, six clones of CHO cells carrying the synthetic gene
hah5 (CHO-HAH5) and producing high levels of the HAH5 protein
were selected (Fig. 2B). These CHO-HAH5 clones exhibited an OD
over 0,50. The clone CHO-HAH5 78 showed the highest production
level of the HAH5 protein with an OD of 0,78. The OD values of
the positive and the negative controls were 0,89 and 0,085, respec-
tively. The HAH5 production level of the clone CHO-HAH5 78 was
signiﬁcantly superior to that of the clones CHO-HAH5 12 (p<0,001),
CHO-HAH5 70 (p<0,05) and CHO-HAH5 76 (p<0,01). DNA inser-
tion in the genome of CHO-HAH5 clones was veriﬁed by PCR using
speciﬁc primers to amplify a DNA fragment of the lentiviral vec-
tor (Fig. 2C) and a fragment of the synthetic gene coding the HAH5
protein (Fig. 2D). The chromosomal DNA of each CHO-HAH5 clone
was used as template. The six clones of CHO-HAH5 tested showed a
DNA band of 500bp corresponding to a fragment of the genome of
the lentiviral vector and a DNA band of 734bp corresponding to a
fragment of the hah5 gene. There was no DNA ampliﬁcation in the
negative controls in which the chromosomal DNA of the wild type
CHO cell line was used as template.
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Fig. 1. Expression of the gene coding the HAH5 protein in HEK-293 cells. (A) Scheme representing the plasmid pAEC-hah5. Kanr, gene for kanamycin resistance; CMVp,
cytomegalovirus major immediate-early promoter/enhancer; HAH5, sequence coding for the extracellular segment of the HA protein from the highly pathogenic strain H5N1
A/Viet Nam 1203/2004; PA, cleavage and polyadenylation sequence; Ori, bacteria’s replication origin ColE1. Light ﬁeld (B) and dark ﬁeld (C) of HEK-293 cells transduced
with the plasmid pAEC-hah5 observed to the ﬂuorescence microscope at a magniﬁcation of 400×. SDS-PAGE (D) and western blot (E) of trichloroacetic acid-precipitated
supernatant of HEK-293 cells transfected with the plasmid pAEC-hah5. (1) Proteins used as molecular weight marker. (2) Supernatant of non-transfected HEK-293 cells under
non-reducing conditions. (3) Supernatant of non-transfected HEK-293 cells under reducing conditions. (4) Supernatant of transfected HEK-293 cells under non-reducing
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Conditions. (5) Supernatant of transfected HEK-293 cells under reducing conditions
or the immunoidentiﬁcation of the HAH5 protein. It was provided by a laboratory
DV. Batch 4/06.
.2. Adaptation of the stable transformed CHO-HAH5 cells to
uspension culture and puriﬁcation of the HAH5 protein
Due to the cloneCHO-HAH5 78exhibited thehighest levels of the
AH5 protein measured by ELISA, it was selected for being adapted
o suspension culture. The gradual medium change from DMEM
lus FCS to SFM4CHO made the cells to detach of the polystyrene
urface and successfully adapted to suspended culturewith stirring
Fig. 3A and B). The initial inoculum for scaling up the suspen-
ion culture to the volume of 1 l in spinners was 2,5×104 cells/mL
Fig. 3C). Two days later, cells increased twofold their concentra-
ion and began to growuntil reachingmore than 3×105 cells/mL at
ay 7. The next day of culture cells decreased their concentration to
round2,5×105 cells/mLandbecamestableuntil day10.Byday11,
he cell concentration abruptly dropped to almost 1×105 cells/mL.
ell viability ranged between 100% and 80% fromdays 1 to 8. At dayperimmune chicken antiserum raised against an H5N2 inﬂuenza A strain was used
rence from Italy “Istituto Zooproﬁlattico delle Venezie” OIE Laboratory for AI and
9, cell viability began to decrease and by the last day of the exper-
iment there was a 40% of cell viability. The results obtained above
led us to maintain the suspension culture until day 10, where cell
concentration and viability met acceptable values, hence the pro-
duction of the HAH5 protein could be favored. In this sense, the
concentration of the HAH5 protein was measured by ELISA (Fig. 4).
The average production of the HAH5 protein by different batches of
the clone CHO-HAH5 78 in suspension culture was approximately
5,1g/mL. There were no signiﬁcant differences among the indi-
vidual batches analyzed.
The puriﬁcation process of the HAH5 protein obtained in the
culture supernatantwas carriedout by immunoafﬁnity chromatog-
raphy (IC) using a monoclonal antibody against the HAH5 protein
(Fig. 5). The graphic of absorbance versus time showed a well-
deﬁned peak when the elution buffer was applied to the matrix
(Fig. 5A)which could correspond to the elution of theHAH5 protein.
112 A.G. Pose et al. / Biotechnology Reports 3 (2014) 108–116
Fig. 2. Transduction of CHO cells with the lentiviral vector Lv-hah5. (A) Scheme
representing the most important characteristics of Lv-hah5. SIN 5′ LTR, 5′ self-
inactivating long terminal repeat; , packaging signal; RRE, Rev response element;
cPPT, central polypurine track; CMVp, cytomegalovirusmajor immediate-early pro-
moter/enhancer; HAH5, sequence coding for the extracellular segment of the HA
protein from the highly pathogenic strain H5N1 A/Viet Nam 1203/2004; WPRE,
post-regulatory element derived from woodchuck hepatitis virus; PA, cleavage and
polyadenylation sequence; SIN 3′ LTR, 3′ self-inactivating long terminal repeat. (B)
ELISA detecting OD450 values of CHO-HAH5 clones. Data represent the arithmetic
mean of nine replicates per CHO-HAH5 clone. Negative control (NC): supernatant of
untransduced CHO cells. Positive control (PC): Protein HAH5 (1g/mL) puriﬁed by
immunoafﬁnity chromatography. Bars represent the standard deviation. OD val-
ues were compared using a Kruskal–Wallis test and a Dunn post-test. *p<0,05;
**p<0,01; ***p<0,001. (C) PCR bands obtained from CHO-HAH5 cells using chro-
mosomal DNA as template and primers speciﬁc for a backbone fragment of the
lentiviral vector. (D) PCR bands obtained from CHO-HAH5 cells using chromosomal
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Fig. 3. Kinetic progression of the stable transformed clone CHO-HAH5 78 in sus-
pension culture. (A) Monolayer of adherent CHO cells. (B) CHO cells adapted to
teins [13,14]. The HAH5 protein obtained by this method was also
used to perform ELISA assays directly from the culture supernatant
or in its puriﬁed form. Although the HAH5 protein was producedNA as template and primers speciﬁc for a fragment of hah5 gene. (1) Clone 5; (2)
lone 12; (3) Clone 45; (4) Clone 70; (5) Clone 76; (6) Clone 78; (7) negative control:
ntransduced CHO cells.
DS-PAGE and western blot assays revealed that the peak observed
fter elution in the graphic of absorbance versus time was indeed
he elution of the HAH5 protein (Fig. 5B and C). The immunoreac-
ive band pattern was the same compared to the observed during
he transient transfection of HEK-293 cells. The bands correspond-
ng to the precursor protein HAH50 and the subunits HAH51 and
AH52 were detected. A portion of the HAH5 protein was lost in
he material not retained to the matrix, which was not observed
uring the wash of the matrix. The HAH5 protein puriﬁed by IC was
btained with more than 95% of purity as estimated by a SDS-PAGE
ensitometric analysis.
.3. Establishment of ELISA assays to detect antibodies against
he HAH5 protein
The production of the HAH5 protein in a suspension culture sys-
emallowedtoobtainenoughprotein toperformimmunodetection
ssays type ELISA with the aim of detecting antibodies against this
rotein. When plates were coated with the HAH5 protein puriﬁed
y IC from the supernatant of the clone CHO-HAH5 78, a decrease
n the OD values was observed as the sera dilution was increased
Fig. 6A). The comparison between dilutions 1/500 and 1/1000 ofsuspension culture. Microscopic pictures of cells were observed at a magniﬁcation
of 400×. (C) Graphic showing cell concentration and cell viability. Data represent the
arithmeticmean of three replicates per point. Bars represent the standard deviation.
positive and negative sera showed the most divergent OD values.
The dilution of 1/500 exhibited an average OD value of around 0,93
for the positive serum and around 0,28 for the negative serum. In
the dilution 1/1000, the average OD value dropped rapidly to about
0,53 in the positive serum and continued diminishing gradually.
The dilution 1/1000 made with the negative serum decreased to an
average OD value of about 0,23 and also the decreased pattern was
sustained until the last dilution tested. A similar experiment was
performed with the HAH5 protein directly from the culture super-
natant of the clone CHO-HAH5 78 suspension culture (Fig. 6B). The
average OD values in the dilutions 1/500 and 1/1000 for the posi-
tive serumwere 0,81 and0,51 and for the negative serumwere 0,29
and 0,23, respectively. This assay repeated the decreased pattern in
the OD values for the next sera dilutions.
In our laboratories, a distinct expression system was already
used to successfully produce the HAH5 protein, in which the syn-
thetic gene coding this molecule was inserted in an adenoviral
vector and used for the transduction of SiHa cells [8]. We had
used this expression system for producing several chimeric pro-Fig. 4. Quantiﬁcation of theHAH5 protein in the supernatant obtained fromdifferent
batches of the clone CHO-HAH5 78 in suspension culture. OD values were compared
using an ANOVA test and a Tukey post-test. Data represent the arithmetic mean of
ﬁve replicates per point. Bars represent the standard deviation.
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Fig. 5. Puriﬁcation of the HAH5 protein by immunoafﬁnity chromatography. (A)
Graphic of absorbance versus time. Arrow head indicates the elution of the HAH5
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he puriﬁcation process. (1) Proteins used as molecular weight marker; (2) initial
ample; (3) non-attached proteins; (4) wash; (5) elution.
n a distinct expression system, the ELISA results using the same
onditions as above were very similar. Plates coated with the HAH5
rotein puriﬁed by IC from the supernatant of transduced SiHa cells
howed the same decreased pattern in the averageOD valueswhen
era dilutions were increased (Fig. 6C). The averages OD of positive
ndnegative sera at dilution1/500were0,91 and0,29, respectively.
n the sera dilutions 1/1000, the average OD for the positive serum
as 0,56 and for the negative serum was 0,20. The OD values for
he other dilutions continued decreasing. In plates coated with the
AH5 protein directly from the culture supernatant of transduced
iHa cells, the average OD for the dilution 1/500 was 0,79 for the
ositive serum and 0.30 for the negative serum (Fig. 6D). The dilu-
ion 1/1000 showed OD values of 0,46 and 0,21 for the positive and
he negative serum, respectively. The expected decreased kinetic
n OD values for the other sera dilutions was also observed in this
ssay. The statistical analysis comparing point to point the average
D values of the ELISA assays coating with the HAH5 protein from
hedifferent expression systems in itspuriﬁed formordirectly from
he culture supernatant did not show signiﬁcant differences.
.4. Antibody detection in the sera of chickens immunized with
he HACD protein having a proper or a non-proper conformation
There is evidence that the renaturation process after the puriﬁ-
ation of the HAH5 protein fused to the chicken CD154 molecule
HACD) by IC could affect the proper conformation of this molecule
8]. Thus, theHAH5 proteins puriﬁed by IC (HAH5IC) or directly from
he culture supernatant of transformed CHO cells (HAH5sC) were
sed to coat ELISA plates in order to evaluate its capacity to bind
ntibodies induced by the HACD protein puriﬁed by IC (HACD IC)
r by size exclusion chromatography (SEC) (Fig. 7). For the positiveeports 3 (2014) 108–116 113
control, wells coated with HACD puriﬁed by SEC (HACD SEC) and
the sera of chickens immunized with the same protein were used.
In the negative control, measures were carried out coating with the
protein HACD SEC and using the sera of chickens immunized with
PBS. The ELISA assay coated with the protein HAH5IC showed OD
values of 0.61 when the sera of chickens immunized with HACD IC
were tested (Fig. 7A), indicating theexistenceof anti-HAH5 antibod-
ies. The proteins HAH5sC and the one obtained in the supernatant
of SiHa cells transduced with a recombinant adenoviral vector
(HAH5sS) were also able to bind antibodies from the chicken sera
used in the previous experiment showing OD values of 0.67 and
0.63, respectively (Fig. 7B). More interestingly, the ELISA assay per-
formed with the protein HAH5IC detected anti-HAH5 antibodies in
the sera of chicken immunized with the protein HACD SEC, show-
ing an OD value of 0.69 (Fig. 7C). In all cases, positive and negative
controls showed OD values around 0.95 and 0.09, respectively.
4. Discussion
After the emergence of the HPAIV H5N1, poultry and human
health have been compromised. Also, it has caused a serious eco-
nomic trouble owing to the obstruction of poultry trade industry
worldwide [15]. The Food and Agriculture Organization of the
United Nations (FAO) and the World Organization for Animal
Health (OIE) havemade huge efforts to organize accurate strategies
for circumventing or diminishing the damages caused by the H5N1
virus. Among them, a vaccination program together with biosafety
measureswhich include surveillance, quarantine and sanitationare
crucial [16–18]. Establishing analytical methods for differentiating
infected from vaccinated animal (DIVA) and surveillance require
a strong platform for protein production, which need a robust and
reliable expression systemable to produce large amount of protein.
In this study, an expression system based on the stable transduc-
tion of CHO cells with a recombinant lentiviral vector carrying a
synthetic gene with the coding sequence of the HA protein from
theHPAIVH5N1was assessed. The generation of genes by chemical
synthesis allows the obtaining of the desired genes in a short period
of time, avoidsmanipulationof strains fromHPAIV, the codonusage
could be rearranged according to the expression system and allows
the addition or removal of regulatory sequences that modulate the
expression of the gene of interest. The molecule HA derived from
the HPAIV H5N1 A/Viet-Nam/1203/2004 was selected for being
lethal to chickens, ducks, ferrets and humans [19,20].
During transient transduction of the cell line HEK-293 with
the synthetic gene carrying the nucleotide sequence of the HAH5
protein, it was successfully expressed and the HAH5 protein was
secreted to the culture supernatant. The band pattern observed in
the western blot assay was very similar to the one obtained in our
previous studieswhen the samesynthetic genewas introduced into
an adenoviral platformand expressed inHC11 [2] and SiHa cells [8].
TheHAmolecule of inﬂuenza viruses typeA is themost representa-
tive molecule of the viral envelope, which is distributed in trimers.
Each monomer contains the subunits HA1 and HA2, which are
the product of the proteolytic cleavage of the precursor molecule
HA0 [21]. This proteolytic cleavage is essential for viral infectiv-
ity and it is the most important pathogenicity determinant for
avian and human hosts. This cleavage is regulated by the molecule
structure and the proteases involved in the viral activation [22].
Low pathogenic avian inﬂuenza strains have a monobasic cleav-
age site susceptible to trypsin-like proteases. Highly pathogenic
avian inﬂuenza strains have a multibasic cleavage site accessible to
subtilysin proteases. They have a wide distribution among several
cellular types. For this reason, viral infection spreads to multiple
tissues, causing systemic infections and the host death [23]. The
in vitro expression of the gene coding the HA protein from a low
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Fig. 6. ELISA assays for detecting anti-HAH5 antibodies coating with the HAH5 protein produced in different cell lines. Anti-HAH5 antibodies detection coating with 2.5g/mL
of the HAH5 protein which was obtained from the supernatant of clone CHO-HAH5 78 in its puriﬁed form (A) or cultured in suspension (B). Also, the ELISA plates were coated
with the HAH5 protein puriﬁed from SiHa cells transiently transduced with a recombinant adenoviral vector (C) or directly from the culture supernatant of this expression
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system (D). Negative and positive reference sera were purchased from a reference labora
atch 4/06 for the positive serum and batch 2/06 for the negative serum. Data were com
he arithmetic mean of six replicates per point. Bars represent the standard deviation.
ig. 7. Antibody detection by ELISA coating with the HAH5 protein produced by suspensio
ulture supernatant of CHO or SiHa cells. (A) Antibody levels in sera of chickens immuni
n CHO cells also puriﬁed by IC. (B) Antibody levels in sera of chickens immunized with
upernatant of CHO (HAsC) or SiHa (HAsS) cells. (C) Antibody levels in sera of chickens i
HO cells and puriﬁed by IC. As positive controls, sera of chicken immunized with the pr
egative controls, sera of chicken immunized with PBS were used. The coating was carr
upernatant of both cell lines. Sera of ten immunized chickens per group diluted 1:1000 wtory of Italy “Istituto Zooproﬁlattico delle Venezie” OIE Laboratory for AI and NDV.
pared each time point by the unpaired t-test. NC, negative control. Data represent
n culture of CHO cells puriﬁed by immunoafﬁnity chromatography or directly from
zed with the HACD protein puriﬁed by IC coating with the HAH5 protein obtained
the HACD protein puriﬁed by IC coating with the HAH5 protein from the culture
mmunized with the protein HACD SEC coating with the HAH5 protein obtained in
otein HACD SEC were used. The coating was carried out with the same protein. As
ied out with 2,5g/mL of the HAH5 protein puriﬁed by IC or directly from culture
ere used. S, sera of chickens immunized with; C, coating; NC, negative control.
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athogenic avian inﬂuenza strain requires the addition of trypsin
or the proteolytic cleavage to occur. However, the HA protein
rom a highly pathogenic avian inﬂuenza strain does not need the
ddition of any external protease to be cleaved, the endogenous
roteases of the cell line that secrete the HA protein are able to
leave it [24]. Our studies showed spontaneous proteolytic cleav-
ges of the HAH5 protein, which demonstrate that this molecule
ame fromahighlypathogenic avian inﬂuenza strain.Nevertheless,
nly part of the HAH5 molecule was cleaved. Western blot shows
segment of protein without cleavage corresponding to the pre-
ursor protein HAH50, suggesting an incomplete processing of this
rotein.
The stable production of the HAH5 protein in CHO cells trans-
ucedwith a recombinant lentiviral vector could become a suitable
lternative for controlling and monitoring avian inﬂuenza dis-
ase. This system could produce proteins not only for diagnostic
urposes but also as vaccine candidates and constitute another
alid approach to counteract the spreading of HPAIV H5N1. Avian
nﬂuenza viruses infect eukaryotic cells. Thus, the environment
n which their proteins are produced provides complex post-
ranslation modiﬁcations to the molecules. Speciﬁcally, HA protein
s a highly glycosylated molecule. The type and pattern of glyco-
ylation are important features for the HA protein to perform its
iological function [25]. In humans, inﬂuenza virus subtype H1N1,
he number of potential N-glycosylation sites of the HA protein
re highly controlled. Five potential N-glycosylation sites in the
lobular head of each HA monomer are selected, but only up to
hree are used [26–28]. Also, there seems to be a relationship
etween antigenic variation and the number and position of N-
lycosylation site which can regulate the avidity and speciﬁcity of
he union of the HA protein to its receptor, the inﬂuenza strain vir-
lence and the evasion to antibodies recognition [25]. Prokaryotes
nd inferior eukaryotes expression systems are able to glycosylate
29,30]. However, the glycosylation phenomenon in the traditional
rokaryotic expression systemEscherichia coli is very rare [31]. Infe-
ior eukaryotes, like yeasts, are able to perform N-glycosylation,
ut the hyper-mannosylated glycans attached to the polypeptide
hain are signiﬁcantly different from those of mammalian cells
32]. Although there are some strategies in bacteria and yeast to
fﬁciently obtain the HA molecule as a vaccine candidate able to
onfer protection in mice [6,7], mammalian cells are the closest
lternative to produce a soluble HA protein with post-translational
odiﬁcations similar to the native one, thus preserving the original
roperties of this molecule. In fact, we have already obtained the
AH5 protein in mammalian cell culture able to induce high lev-
ls of HIA in chickens [8]. Also, the protein bands obtained for the
AH5 protein in SDS-PAGE under reducing condition corresponds
o a glycosylated version of this protein, since we have already
emonstrated that the deglycosylation of the HAH5 protein with
he enzyme PNGase-F provides a lower band pattern [8].
In the last decade, mammalian cell culture has become the
ost demanded expression system to obtain complex recombi-
ant proteins in response to their increasing need for structural and
unctional studies and for ﬁeld experiments. There are several cell
ines used for this purpose, such asHEK-293, BHK, NSO, among oth-
rs. However, CHO cells have been so far the most utilized [33,34].
urrently, the majority of recombinant proteins intended to bio-
harmaceutical industry is produced in this cell line because it has
everal advantages with respect to the other cell lines: (i) its safety
s thoroughly demonstrated, so it is easy to overcome regulatory
ssues in order to gain the consent of supervisory institutions; (ii)
ow productivity can be improved by gene ampliﬁcation systems
vailable for CHO cells and (iii) the change of culture conditions
rom adherent serum-dependent to serum-free suspension culture
an be easily achieved for this cells. This is a desired feature for
caling up the production system and to reduce the costs [10]. Alleports 3 (2014) 108–116 115
these characteristics of CHO cells make them a suitable expression
system to produce antigens of the HPAIV H5N1 in a safe way and
with higher quality.
ThecomparisonofODvalues in the immunodetectionassay type
ELISA using the HAH5 protein puriﬁed by IC produced in the CHO
cells stable transformed with a recombinant lentiviral vector or by
transient transduction of SiHa cells with a recombinant adenoviral
vector showed no signiﬁcant differences. The OD values observed
during the antigen–antibody interaction of the positive reference
serum with the HAH5 protein puriﬁed or directly from the cul-
ture supernatant produced in different expression systems were
very similar, as well as the OD values detected when the negative
reference serum was assayed. Despite the differences in the viral
vector and the expression system used, it seems that the HAH5 pro-
tein did not suffer dramatic post-translational changes during its
production and posterior secretion able to alter its recognition by
antibodies. Thus, the use of the HAH5 protein directly from the cul-
ture supernatant for the recognition of anti-HAH5 antibodies could
lower the costs in a large scale process because of the exclusion of
the puriﬁcation stage.
On the other hand, the fact that the HAH5 protein puriﬁed by IC
have showna similar antibody levels comparedwith theunpuriﬁed
variant when the sera of chickens immunized with the HACD pro-
tein puriﬁed by ICwas assayed is a very interesting result. There are
evidences that the renaturation after the acidic elution during the
puriﬁcation by IC of the HACD protein make it inefﬁcient to induce
HIA, while the same protein puriﬁed by SEC is able to induce such
type of antibodies [8]. This suggests that HAH5 molecule puriﬁed
by IC could undergo conformational changes upon renaturation.
Regardless of the failure in inducing hemagglutinating antibod-
ies, the HACD protein puriﬁed by IC is able to trigger a humoral
immune response detected by ELISA containing antibodies able to
recognize both the HAH5 protein puriﬁed by IC or directly from the
culture supernatant. Also, the antibodies induced by theHACDpro-
tein puriﬁed by SEC bind theHAH5 protein puriﬁed by IC. Therefore,
the protein HAH5, although puriﬁed by a method that can affect its
conformation, preserves epitopes able to bind antibodies induced
by a protein with a conformation very close to the native HA. It
suggests there are other antibodies than HIA which are induced
during the immune response against the HA protein that, although
incapable of neutralizing the molecule, can be detected in ELISA
assays using the HA protein puriﬁed by IC. Hence, this protein can
be useful in diagnostic by detecting H5 subtype of avian inﬂuenza
virus.
5. Conclusions
There is no doubt that avian inﬂuenza caused by HPAIV H5N1 is
one of the viral diseases which currently could put in danger poul-
try and all mankind with the sudden appearance of a new strain
able to cross species from birds to human and rapidly propagate
among them. Consequently, there are a lot of research projects
directed to basic investigations for controlling and making better
surveillance methods to eradicate this disease. The present study
focusedon the establishment of a stable CHOcell line producing the
HA protein from HPAIV H5N1 with the main objective of detecting
antibodies against this protein and indeed results demonstrated
that a reference positive serum succeeded in recognizing epitopes
on the HAH5 protein obtained in CHO cells. The production of the
HAH5 protein from a HPAIV is only the beginning from what could
represent a safe and consistent system of producing antigens
from avian inﬂuenza viruses, not only for diagnostic reinforcing
the surveillance, but also for mass producing vaccine candidates
against these viruses. Further experiments must be performed in
order to enhance the stability, the viability and the concentration
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